Literature DB >> 18988

Delineation of the relative antibacterial activity of cefamandole and cefamandole nafate.

J R Turner, D A Preston, J S Wold.   

Abstract

By conventional laboratory evaluation procedures, the in vitro antibacterial activities of cefamandole and its O-formyl ester, cefamandole nafate, appear virtually identical. When the activities of these two compounds were examined for their ability to lyse log-phase cultures of susceptible bacteria, however, cefamandole was found to be about 10 times more active than cefamandole nafate. Cefamandole nafate was shown to be rapidly converted to cefamandole in bacteriological media, with a half-life of less than 1 h at a pH of 7.0 or above. At pH 6.0, in log-phase inhibition experiments, however, cefamandole nafate is more stable, allowing delineation of the activity between cefamandole and cefamandole nafate. The efficacy of cefamandole was identical to that of cefamandole nafate in treating experimental animal infections, indicating that rapid conversion of cefamandole nafate to cefamandole occurs in vivo.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 18988      PMCID: PMC352155          DOI: 10.1128/AAC.12.1.67

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Conversion of cefamandole nafate to cefamandole sodium.

Authors:  J M Indelicato; W L Wilham; B J Cerimele
Journal:  J Pharm Sci       Date:  1976-08       Impact factor: 3.534

2.  Stable antibiotic sensitivity disks.

Authors:  R R Pfeiffer; G L Engel; D Coleman
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

3.  Comparison of the responses of Escherichia coli and proteus mirabilis to seven beta-lactam antibodies.

Authors:  D Greenwood; F O'Grady
Journal:  J Infect Dis       Date:  1973-08       Impact factor: 5.226

4.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

5.  Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibiotics.

Authors:  W E Wick; D A Preston
Journal:  Antimicrob Agents Chemother       Date:  1972-03       Impact factor: 5.191

  5 in total
  4 in total

1.  Metabolic fate of [14C]cefamandole, a parenteral cephalosporin antibiotic, in rats and dogs.

Authors:  H R Sullivan; S L Due; D L Kau; J F Quay; W M Miller
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

2.  Hydrolysis of cefamandole nafate in dialysis patients.

Authors:  R L Nielsen; R Wolen; F C Luft; T Ozawa
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

3.  Comparison of cefamandole nafate to cefamandole by microbiological assay.

Authors:  C L Winely; J C Spears; J K Scott
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

4.  Limited in vitro activity of cefamandole against 100 beta-lactamase- and non-beta-lactamase-producing Haemophilus influenzae strains: comparison of moxalactam, chloramphenicol, and ampicillin.

Authors:  M G Bergeron; S Claveau; P Simard
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.